APA

Zakharenko A. L., Luzina O. A., Sokolov D. N., Kaledin V. I., Nikolin V. P., Popova N. A., Patel J., Zakharova O. D., Chepanova A. A., Zafar A., Reynisson J., Leung E., Leung I. K. H., Volcho K. P., Salakhutdinov N. F. & Lavrik O. I. (20181218). Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topoteсan on in vivo tumor models. : European journal of medicinal chemistry.

Chicago

Zakharenko A L, Luzina O A, Sokolov D N, Kaledin V I, Nikolin V P, Popova N A, Patel J, Zakharova O D, Chepanova A A, Zafar A, Reynisson J, Leung E, Leung I K H, Volcho K P, Salakhutdinov N F and Lavrik O I. 20181218. Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topoteсan on in vivo tumor models. : European journal of medicinal chemistry.

Harvard

Zakharenko A. L., Luzina O. A., Sokolov D. N., Kaledin V. I., Nikolin V. P., Popova N. A., Patel J., Zakharova O. D., Chepanova A. A., Zafar A., Reynisson J., Leung E., Leung I. K. H., Volcho K. P., Salakhutdinov N. F. and Lavrik O. I. (20181218). Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topoteсan on in vivo tumor models. : European journal of medicinal chemistry.

MLA

Zakharenko A L, Luzina O A, Sokolov D N, Kaledin V I, Nikolin V P, Popova N A, Patel J, Zakharova O D, Chepanova A A, Zafar A, Reynisson J, Leung E, Leung I K H, Volcho K P, Salakhutdinov N F and Lavrik O I. Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topoteсan on in vivo tumor models. : European journal of medicinal chemistry. 20181218.